Additional K-ras mutation analysis and Plectin-1 staining improve the diagnostic accuracy of pancreatic solid mass in EUS-guided fine needle aspiration
Year: 2017
Type: article
Study design: Observational Study
Abstract: // Joo Kyung Park 1,* , Woo Hyun Paik 2,4,* , Byeong Jun Song 3,* , Ji Kon Ryu 4 , Min A. Kim 5 , Jin Myung Park 4 , Sang Hyub Lee 4 and Yong-Tae Kim 4 1 Department of Medicine, Division of Gastroenterology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea 2 Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, Korea 3 Department of Internal Medicine, Myongji Hospital, Goyang, Korea 4 Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea 5 Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea * These authors have contributed equally to this work as first authors Correspondence to: Ji Kon Ryu, email: // Keywords : pancreatic ductal adenocarcinoma; endoscopic ultrasound; K-ras; Plectin-1 Received : January 02, 2017 Accepted : March 04, 2017 Published : March 11, 2017 Abstract Background: One of the major genetic alterations in pancreatic ductal adenocarcinoma (PDAC) is the point mutation of K-ras gene. Plectin-1 was also recently identified as PDAC specific biomarker. The aim of this study was to investigate the improvement of diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) by using additional K-ras mutation analysis and Plectin-1 staining in patients with pancreatic mass. Methods: A total of 85 study patients with pancreatic mass underwent EUS-FNA and the final diagnoses were as follows; PDACs: 70 patients, pancreas neuroendocrine tumor: 4, metastasis to pancreas: 5, autoimmune pancreatitis: 3, chronic pancreatitis: 1, tuberculous lymphadenitis: 1, pseudocyst: 1. Results: Sensitivity, specificity and accuracy of pathologic diagnosis in EUS-FNA specimen were 81%, 80% and 79% accordingly. When we combine K-ras gene mutation analysis with histological assessment, we could get the following results for sensitivity, specificity and accuracy; cytology and K-ras mutation analysis: 93%, 87%, and 92%, cytology, K-ras mutation analysis, and Plectin-1 staining: 96%, 93%, and 95%. Conclusions: Triple combinations of the techniques; cytology, K-ras gene mutation analysis, Plectin-1 staining could increase accuracy in diagnosis of PDACs. Further investigation of using minimal specimens from EUS-FNA may give us insight to understand the biological behavior of PDAC.
Source: Oncotarget
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W2592492007